Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1439-7609
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab ; volume:23 ; number:4 ; day:11 ; month:7 ; year:2012 ; pages:827-831 ; date:7.2013
Modern rheumatology ; 23, Heft 4 (11.7.2012), 827-831, 7.2013
- Creator
-
Araki, Manabu
Aranami, Toshimasa
Matsuoka, Takako
Nakamura, Masakazu
Miyake, Sachiko
Yamamura, Takashi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10165-012-0715-9
- URN
-
urn:nbn:de:101:1-2021080920522603311656
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.20252025, 12:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Araki, Manabu
- Aranami, Toshimasa
- Matsuoka, Takako
- Nakamura, Masakazu
- Miyake, Sachiko
- Yamamura, Takashi
- SpringerLink (Online service)
Other Objects (12)
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Neuromyelitis optica
Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab
Interferon-beta-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
Neuromyelitis optica spectrum disorders without and with autoimmune diseases
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
The history of neuromyelitis optica
Different monoclonal antibodies and immunosuppressants administration in patients with neuromyelitis optica spectrum disorder: a Bayesian network meta-analysis
Neuromyelitis optica spectrum disorders with and without connective tissue disorders
Neuromyelitis Optica Spectrum Disorder Coinciding with Spinocerebellar Ataxia Type 31
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Neuromyelitis optica
Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab
Interferon-beta-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
Neuromyelitis optica spectrum disorders without and with autoimmune diseases
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
The history of neuromyelitis optica
Different monoclonal antibodies and immunosuppressants administration in patients with neuromyelitis optica spectrum disorder: a Bayesian network meta-analysis
Neuromyelitis optica spectrum disorders with and without connective tissue disorders
Neuromyelitis Optica Spectrum Disorder Coinciding with Spinocerebellar Ataxia Type 31
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Neuromyelitis optica
Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab
Interferon-beta-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
Neuromyelitis optica spectrum disorders without and with autoimmune diseases
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
The history of neuromyelitis optica
Different monoclonal antibodies and immunosuppressants administration in patients with neuromyelitis optica spectrum disorder: a Bayesian network meta-analysis
Neuromyelitis optica spectrum disorders with and without connective tissue disorders